Your browser doesn't support javascript.
loading
Safety and feasibility of esophagectomy following combined neoadjuvant immunotherapy and chemotherapy for locally advanced esophageal cancer: a propensity score matching.
Hong, Zhi-Nuan; Zhang, Zhenyang; Chen, Zhen; Weng, Kai; Peng, Kaiming; Lin, Jiangbo; Kang, Mingqiang.
Afiliação
  • Hong ZN; Department of Thoracic Surgery, Fujian Medical University Union Hospital, Fuzhou, 350001, People's Republic of China.
  • Zhang Z; Key Laboratory of Cardio-Thoracic Surgery (Fujian Medical University), Fujian Province University, Fuzhou, 350001, People's Republic of China.
  • Chen Z; Department of Thoracic Surgery, Fujian Medical University Union Hospital, Fuzhou, 350001, People's Republic of China.
  • Weng K; Department of Thoracic Surgery, Fujian Medical University Union Hospital, Fuzhou, 350001, People's Republic of China.
  • Peng K; Key Laboratory of Cardio-Thoracic Surgery (Fujian Medical University), Fujian Province University, Fuzhou, 350001, People's Republic of China.
  • Lin J; Department of Thoracic Surgery, Fujian Medical University Union Hospital, Fuzhou, 350001, People's Republic of China.
  • Kang M; Department of Thoracic Surgery, Fujian Medical University Union Hospital, Fuzhou, 350001, People's Republic of China.
Esophagus ; 19(2): 224-232, 2022 04.
Article em En | MEDLINE | ID: mdl-34988773

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Esofágicas / Esofagectomia Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Esofágicas / Esofagectomia Idioma: En Ano de publicação: 2022 Tipo de documento: Article